# European Commission

Type: organization

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/european-commission
Canonical HTML page: https://getbiobrief.com/entity/european-commission

## Recent coverage (1 stories)

### ImmunityBio Shares Surge as EU Approves ANKTIVA for Bladder Cancer
2026-02-18 23:26:51 · Sentiment: Bullish · Impact: 7/10 · Sources: 3

ImmunityBio (IBRX) shares rallied following the European Commission's marketing authorization of ANKTIVA for BCG-unresponsive non-muscle invasive bladder cancer. This milestone marks the first international expansion for the IL-15 superagonist, significantly broadening its global commercial reach.
Full story: https://getbiobrief.com/story/immunitybio-anktiva-eu-approval-bladder-cancer

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.